Computer models can make transcranial electric stimulation a better tool for research and therapy.
The human brain seems well protected, encased within the skull. Yet something as simple as placing a pair of wet sponges onto someone's head and sending a weak electric current between them can actually alter the brain's activity. A refined version of this method – known as transcranial electric stimulation – has attracted considerable interest and is now being used to probe the workings of the brain and develop treatments for medical conditions such as depression, epilepsy or stroke.
Transcranial electric stimulation (or TES for short) has parallels with conventional drug treatments in the sense that delivering an electric field to the brain is analogous to delivering drug molecules into the body. So, just as it is important to know how the human body affects an administered drug (a field of research that is known as pharmacokinetics), in TES we need to know how much of the current applied to the scalp actually enters the brain, and where this current goes.
The 'pharmacokinetics of TES' remains contentious (Underwood, 2016), but is important for several reasons. First, it allows us to relate findings from experiments in which brain tissue from animals is stimulated directly to findings obtained via noninvasive applications in people. Second, it helps researchers optimize the process in order to target specific regions of the brain. Third, it enables researchers to compensate for the differences between individuals, and to standardize the exposure that they receive.
The only established approach for estimating the dose of TES delivered to an individual relies on a three-dimensional model of the subject's head that includes its different tissues and the attached electrodes, which is fed into a computer simulation (Figure 1). Such models have been available for some time (Datta et al., 2009), but they had been validated only partially and indirectly in humans or other primates (Edwards et al., 2013; Lee et al., 2015). Moreover, there are uncertainties about the electric properties of the tissues in these models.
Now, in eLife, Lucas Parra and colleagues – including Yu Huang and Anli Liu as joint first authors – report how they have addressed these issues by combining elaborate computational modeling with recordings taken within the brains of ten people undergoing surgery for epilepsy (Huang et al., 2017). This sample size markedly exceeds that of other similar measurements (Opitz et al., 2016), and the three-dimensional models used are highly sophisticated too. Leveraging this setup, Huang et al. provide the most extensive and direct estimates of the TES electric field to date. They also confirm that computational models of TES can accurately recreate the electric field generated in a real brain.
Huang et al. – who are based at City College of the City University of New York, New York University School of Medicine and the Mayo Clinic – provide practical insights that should help others to implement the models as well. For accurate results, the individual scan should capture the entire head, from neck to crown. This is not the convention in clinical imaging, which currently only focuses on the brain, but Huang et al. get round this limitation by splicing the bottom portion of a standard model of a head onto the individual scans. To do this, the images must be properly cropped and morphed, though this feature has yet to be added to publicly available electric field modeling software.
Including a compartment for the cerebrospinal fluid (the colorless liquid that surrounds the brain) also makes the models more accurate. Appropriate imaging and image analysis methods are required to capture this layer as well as the skull, which are both quite thin (see Figure 1B). However, modelers can breathe a sigh of relief, because the data suggest that the different layers within the skull can be omitted from the models without significantly impacting their accuracy. The way that conductivity changes depending on the orientation of the current in the brain's white matter can similarly be ignored, at least for the mostly outer regions of the brain explored so far by Huang et al.
This work also underscores the present limitations of modeling. It is still uncertain exactly what values for tissue conductivity should be used, and whether it is acceptable to use the same values for everyone. Addressing this question requires further studies likely involving a range of techniques. For example, there are promising efforts to measure tissue conductivities directly during surgery (Koessler et al., 2017), or with other noninvasive techniques (Chauhan et al., 2017).
Even without making the absolute electric field estimates more accurate, existing modeling approaches and software appear suitable for measuring the relative strength of stimulation across brain regions, and predicting how an individual's anatomy might affect this. Indeed, the National Institutes of Health now requires that researchers applying for certain grants "use realistic head modeling" to characterize what electric field is delivered across the brain (NIH, 2017). All in all, it seems that the time is now right for wider adoption of 'pharmacokinetics' of transcranial brain stimulation.
Multishot echo-planar MREIT for fast imaging of conductivity, current density, and electric field distributionsMagnetic Resonance in Medicine, 10.1002/mrm.26638, 28205251.
Electric field model of transcranial electric stimulation in nonhuman primates: correspondence to individual motor thresholdIEEE Transactions on Biomedical Engineering 62:2095–2105.https://doi.org/10.1109/TBME.2015.2425406
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
The formation of oligomers of the amyloid-β peptide plays a key role in the onset of Alzheimer's disease. We describe herein the investigation of disease-relevant small amyloid-β oligomers by mass spectrometry and ion mobility spectrometry, revealing functionally relevant structural attributes. In particular, we can show that amyloid-β oligomers develop in two distinct arrangements leading to either neurotoxic oligomers and fibrils or non-toxic amorphous aggregates. Comprehending the key-attributes responsible for those pathways on a molecular level is a pre-requisite to specifically target the peptide's tertiary structure with the aim to promote the emergence of non-toxic aggregates. Here, we show for two fibril inhibiting ligands, an ionic molecular tweezer and a hydrophobic peptide that despite their different interaction mechanisms, the suppression of the fibril pathway can be deduced from the disappearance of the corresponding structure of the first amyloid-β oligomers.
Research on the neural basis of conscious perception has almost exclusively shown that becoming aware of a stimulus leads to increased neural responses. By designing a novel form of perceptual filling-in (PFI) overlaid with a dynamic texture display, we frequency-tagged multiple disappearing targets as well as their surroundings. We show that in a PFI paradigm, the disappearance of a stimulus and subjective invisibility is associated with increases in neural activity, as measured with steady-state visually evoked potentials (SSVEPs), in electroencephalography (EEG). We also find that this increase correlates with alpha-band activity, a well-established neural measure of attention. These findings cast doubt on the direct relationship previously reported between the strength of neural activity and conscious perception, at least when measured with current tools, such as the SSVEP. Instead, we conclude that SSVEP strength more closely measures changes in attention.